The somatotropic axis and aging: Benefits of endocrine defects

Growth Hormone and IGF Research

Volumn 27, Issue , 2016, Pages 41-45

  Bartke, Andrzej ^a   List, Edward O ^b,c   Kopchick, John J ^b,c  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b OHIO UNIVERSITY   (United States)

^c OHIO UNIVERSITY   (United States)

Author keywords

Adipose tissue; Growth hormone; Growth hormone receptors; IGF 1; Liver; Longevity; Muscle

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE RECEPTOR; MAMMALIAN TARGET OF RAPAMYCIN; SOMATOMEDIN C;

AGING; ENDOCRINE DISEASE; ENERGY METABOLISM; GENE DELETION; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE SECRETING CELL; HORMONAL REGULATION; HORMONE ACTION; HORMONE RESISTANCE; HUMAN; LIPID DIET; LONGEVITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; ENDOCRINE SYSTEM; METABOLISM; MOUSE; PHYSIOLOGY;

AGING; ANIMALS; ENDOCRINE SYSTEM; ENERGY METABOLISM; GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; LONGEVITY; MICE; RECEPTORS, SOMATOTROPIN;

EID: 84961770724     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2016.02.002     Document Type: Review

References (79)

1. Brown-Borg H.M., Borg K.E., Meliska C.J., Bartke A. Dwarf mice and the ageing process. Nature 1996, 384:33.
2. Flurkey K., Papaconstantinou J., Miller R.A., Harrison D.E. Lifespan extension and delayed immune and collagen aging in mutant mice with defects in growth hormone production. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:6736-6741.
3. Coschigano K.T., Clemmons D., Bellush L.L., Kopchick J.J. Assessment of growth parameters and lifespan of GHR/BP gene-disrupted mice. Endocrinology 2000, 141:2608-2613.
4. Bartke A., Brown-Borg H. Life extension in the dwarf mouse. Curr. Top. Dev. Biol. 2004, 63:189-225.
5. Bartke A. Single-gene mutations and healthy ageing in mammals. Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci. 2011, 366:28-34.
6. Brown-Borg H.M. Hormonal control of aging in rodents: the somatotropic axis. Mol. Cell. Endocrinol. 2009, 299:64-71.
7. Bartke A., Sun L.Y., Longo V. Somatotropic signaling: trade-offs between growth, reproductive development, and longevity. Physiol. Rev. 2013, 93:571-598.
8. Sluczanowska-Glabowska S., Laszczynska M., Piotrowska K., Glabowski W., Kopchick J.J., Bartke A., Kucia M., Ratajczak M.Z. Morphology of ovaries in laron dwarf mice, with low circulating plasma levels of insulin-like growth factor-1 (IGF-1), and in bovine GH-transgenic mice, with high circulating plasma levels of IGF-1. J. Ovarian Res. 2012, 5:18.
9. Schneider A., Zhi X., Moreira F., Lucia T., Mondadori R.G., Masternak M.M. Primordial follicle activation in the ovary of Ames dwarf mice. J. Ovarian Res. 2014, 7:120.
10. Greer K.A., Hughes L.M., Masternak M.M. Connecting serum IGF-1, body size, and age in the domestic dog. Age (Dordr.) 2011, 33:475-483.
11. Paradis M.R. Demographics of health and disease in the geriatric horse. Vet. Clin. North Am. Equine Pract. 2002, 18:391-401.
12. van Heemst D., Beekman M., Mooijaart S.P., Heijmans B.T., Brandt B.W., Zwaan B.J., Slagboom P.E., Westendorp R.G. Reduced insulin/IGF-1 signalling and human longevity. Aging Cell 2005, 4:79-85.
13. Milman S., Atzmon G., Huffman D.M., Wan J., Crandall J.P., Cohen P., Barzilai N. Low insulin-like growth factor-1 level predicts survival in humans with exceptional longevity. Aging Cell 2014, 13:769-771.
14. Kimura K.D., Tissenbaum H.A., Liu Y., Ruvkun G. Daf-2, an insulin receptor-like gene that regulates longevity and diapause in Caenorhabditis elegans. Science 1997, 277:942-946.
15. Morris J.Z., Tissenbaum H.A., Ruvkun G. A phosphatidylinositol-3-OH kinase family member regulating longevity and diapause in Caenorhabditis elegans. Nature 1996, 382:536-539.
16. Guarente L., Kenyon C. Genetic pathways that regulate ageing in model organisms. Nature 2000, 408:255-262.
17. Longo V.D., Finch C.E. Evolutionary medicine: from dwarf model systems to healthy centenarians?. Science 2003, 299:1342-1346.
18. Fushan A.A., Turanov A.A., Lee S.G., Kim E.B., Lobanov A.V., Yim S.H., Buffenstein R., Lee S.R., Chang K.T., Rhee H., Kim J.S., Yang K.S., Gladyshev V.N. Gene expression defines natural changes in mammalian lifespan. Aging Cell 2015, 14:352-365.
19. Coschigano K.T., Holland A.N., Riders M.E., List E.O., Flyvbjerg A., Kopchick J.J. Deletion, but not antagonism, of the mouse growth hormone receptor results in severely decreased body weights, insulin, and insulin-like growth factor I levels and increased life span. Endocrinology 2003, 144:3799-3810.
20. Alba M., Salvatori R. A mouse with targeted ablation of the growth hormone-releasing hormone gene: a new model of isolated growth hormone deficiency. Endocrinology 2004, 145:4134-4143.
21. Sun L.Y., Spong A., Swindell W.R., Fang Y., Hill C., Huber J.A., Boehm J.D., Westbrook R., Salvatori R., Bartke A. Growth hormone-releasing hormone disruption extends lifespan and regulates response to caloric restriction in mice. Elife 2013, 2.
22. Stabnov L., Kasukawa Y., Guo R., Amaar Y., Wergedal J.E., Baylink D.J., Mohan S. Effect of insulin-like growth factor-1 (IGF-1) plus alendronate on bone density during puberty in IGF-1-deficient MIDI mice. Bone 2002, 30:909-916.
23. Lorenzini A., Salmon A.B., Lerner C., Torres C., Ikeno Y., Motch S., McCarter R., Sell C. Mice producing reduced levels of insulin-like growth factor type 1 display an increase in maximum, but not mean, life span. J. Gerontol. A Biol. Sci. Med. Sci. 2014, 69:410-419.
24. Salmon A.B., Lerner C., Ikeno Y., Motch Perrine S.M., McCarter R., Sell C. Altered metabolism and resistance to obesity in long-lived mice producing reduced levels of IGF-I. Am. J. Physiol. Endocrinol. Metab. 2015, 308:E545-E553.
25. Holzenberger M., Dupont J., Ducos B., Leneuve P., Geloen A., Even P.C., Cervera P., Le Bouc Y. IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature 2003, 421:182-187.
26. Bokov A.F., Garg N., Ikeno Y., Thakur S., Musi N., DeFronzo R.A., Zhang N., Erickson R.C., Gelfond J., Hubbard G.B., Adamo M.L., Richardson A. Does reduced IGF-1R signaling in Igf1r+/- mice alter aging?. PLoS One 2011, 6.
27. Xu J., Gontier G., Chaker Z., Lacube P., Dupont J., Holzenberger M. Longevity effect of IGF-1R(+/-) mutation depends on genetic background-specific receptor activation. Aging Cell 2014, 13:19-28.
28. Selman C., Lingard S., Choudhury A.I., Batterham R.L., Claret M., Clements M., Ramadani F., Okkenhaug K., Schuster E., Blanc E., Piper M.D., Al-Qassab H., Speakman J.R., Carmignac D., Robinson I.C., Thornton J.M., Gems D., Partridge L., Withers D.J. Evidence for lifespan extension and delayed age-related biomarkers in insulin receptor substrate 1 null mice. FASEB J. 2008, 22:807-818.
29. Selman C., Tullet J.M., Wieser D., Irvine E., Lingard S.J., Choudhury A.I., Claret M., Al-Qassab H., Carmignac D., Ramadani F., Woods A., Robinson I.C., Schuster E., Batterham R.L., Kozma S.C., Thomas G., Carling D., Okkenhaug K., Thornton J.M., Partridge L., Gems D., Withers D.J. Ribosomal protein S6 kinase 1 signaling regulates mammalian life span. Science 2009, 326:140-144.
30. Strong R., Miller R.A., Astle C.M., Floyd R.A., Flurkey K., Hensley K.L., Javors M.A., Leeuwenburgh C., Nelson J.F., Ongini E., Nadon N.L., Warner H.R., Harrison D.E. Nordihydroguaiaretic acid and aspirin increase lifespan of genetically heterogeneous male mice. Aging Cell 2008, 7:641-650.
31. Harrison D.E., Strong R., Allison D.B., Ames B.N., Astle C.M., Atamna H., Fernandez E., Flurkey K., Javors M.A., Nadon N.L., Nelson J.F., Pletcher S., Simpkins J.W., Smith D., Wilkinson J.E., Miller R.A. Acarbose, 17-alpha-estradiol, and nordihydroguaiaretic acid extend mouse lifespan preferentially in males. Aging Cell 2014, 13:273-282.
32. Austad S.N., Bartke A. Sex differences in longevity and in responses to anti-aging interventions: a mini-review. Gerontology 2015.
33. Singer K., Maley N., Mergian T., DelProposto J., Cho K.W., Zamarron B.F., Martinez-Santibanez G., Geletka L., Muir L., Wachowiak P., Demirjian C., Lumeng C.N. Differences in hematopoietic stem cells contribute to sexually dimorphic inflammatory responses to high fat diet-induced obesity. J. Biol. Chem. 2015, 290:13250-13262.
34. Mode A., Gustafsson J.A. Sex and the liver - a journey through five decades. Drug Metab. Rev. 2006, 38:197-207.
35. Waxman D.J., LeBlanc G.A., Morrissey J.J., Staunton J., Lapenson D.P. Adult male-specific and neonatally programmed rat hepatic P-450 forms RLM2 and 2a are not dependent on pulsatile plasma growth hormone for expression. J. Biol. Chem. 1988, 263:11396-11406.
36. Conover C.A. PAPP-A: a new anti-aging target?. Aging Cell 2010, 9:942-946.
37. Conover C.A. Role of PAPP-A in aging and age-related disease. Exp. Gerontol. 2013, 48:612-613.
38. Yang T., Householder L.A., Lubbers E.R., List E.O., Troike K., Vesel C., Duran-Ortiz S., Kopchick J.J., Berryman D.E. Growth hormone receptor antagonist transgenic mice are protected from hyperinsulinemia and glucose intolerance despite obesity when placed on a HF diet. Endocrinology 2015, 156:555-564.
39. Berryman D.E., List E.O., Kohn D.T., Coschigano K.T., Seeley R.J., Kopchick J.J. Effect of growth hormone on susceptibility to diet-induced obesity. Endocrinology 2006, 147:2801-2808.
40. Gong Z., Kennedy O., Sun H., Wu Y., Williams G.A., Klein L., Cardoso L., Matheny R.W., Hubbard G.B., Ikeno Y., Farrar R.P., Schaffler M.B., Adamo M.L., Muzumdar R.H., Yakar S. Reductions in serum IGF-1 during aging impair health span. Aging Cell 2014, 13:408-418.
41. Rollo C.D., Carlson J., Sawada M. Accelerated aging of giant transgenic mice is associated with elevated free radical processes. Can. J. Zool. 1996, 74:606-620.
42. Bartke A. Can growth hormone (GH) accelerate aging? Evidence from GH-transgenic mice. Neuroendocrinology 2003, 78:210-216.
43. Fan Y., Fang X., Tajima A., Geng X., Ranganathan S., Dong H., Trucco M., Sperling M.A. Evolution of hepatic steatosis to fibrosis and adenoma formation in liver-specific growth hormone receptor knockout mice. Front. Endocrinol. 2014, 5:218.
44. Mavalli M.D., DiGirolamo D.J., Fan Y., Riddle R.C., Campbell K.S., van Groen T., Frank S.J., Sperling M.A., Esser K.A., Bamman M.M., Clemens T.L. Distinct growth hormone receptor signaling modes regulate skeletal muscle development and insulin sensitivity in mice. J. Clin. Invest. 2010, 120:4007-4020.
45. Vijayakumar A., Wu Y., Sun H., Li X., Jeddy Z., Liu C., Schwartz G.J., Yakar S., LeRoith D. Targeted loss of GHR signaling in mouse skeletal muscle protects against high-fat diet-induced metabolic deterioration. Diabetes 2012, 61:94-103.
46. List E.O., Berryman D.E., Funk K., Gosney E.S., Jara A., Kelder B., Wang X., Kutz L., Troike K., Lozier N., Mikula V., Lubbers E.R., Zhang H., Vesel C., Junnila R.K., Frank S.J., Masternak M.M., Bartke A., Kopchick J.J. The role of GH in adipose tissue: lessons from adipose-specific GH receptor gene-disrupted mice. Mol. Endocrinol. 2013, 27:524-535.
47. List E.O., Berryman D.E., Funk K., Jara A., Kelder B., Wang F., Stout M.B., Zhi X., Sun L., White T.A., LeBrasseur N.K., Pirtskhalava T., Tchkonia T., Jensen E.A., Zhang W., Masternak M.M., Kirkland J.L., Miller R.A., Bartke A., Kopchick J.J. Liver-specific GH receptor gene-disrupted (LiGHRKO) mice have decreased endocrine IGF-I, increased local IGF-I, and altered body size, body composition, and adipokine profiles. Endocrinology 2014, 155:1793-1805.
48. Wu Y., Liu C., Sun H., Vijayakumar A., Giglou P.R., Qiao R., Oppenheimer J., Yakar S., LeRoith D. Growth hormone receptor regulates beta cell hyperplasia and glucose-stimulated insulin secretion in obese mice. J. Clin. Invest. 2011, 121:2422-2426.
49. Lu C., Kumar P.A., Sun J., Aggarwal A., Fan Y., Sperling M.A., Lumeng C.N., Menon R.K. Targeted deletion of growth hormone (GH) receptor in macrophage reveals novel osteopontin-mediated effects of GH on glucose homeostasis and insulin sensitivity in diet-induced obesity. J. Biol. Chem. 2013, 288:15725-15735.
50. List E.O., Berryman D.E., Ikeno Y., Hubbard G.B., Funk K., Comisford R., Young J.A., Stout M.B., Tchkonia T., Masternak M.M., Bartke A., Kirkland J.L., Miller R.A., Kopchick J.J. Removal of growth hormone receptor (GHR) in muscle of male mice replicates some of the health benefits seen in global GHR-/- mice. Aging (Albany NY) 2015.
51. Yakar S., Setser J., Zhao H., Stannard B., Haluzik M., Glatt V., Bouxsein M.L., Kopchick J.J., LeRoith D. Inhibition of growth hormone action improves insulin sensitivity in liver IGF-1-deficient mice. J. Clin. Invest. 2004, 113:96-105.
52. Dominick G., Berryman D.E., List E.O., Kopchick J.J., Li X., Miller R.A., Garcia G.G. Regulation of mTOR activity in Snell dwarf and GH receptor gene-disrupted mice. Endocrinology 2015, 156:565-575.
53. Berryman D.E., List E.O., Coschigano K.T., Behar K., Kim J.K., Kopchick J.J. Comparing adiposity profiles in three mouse models with altered GH signaling. Growth Hormon. IGF Res. 2004, 14:309-318.
54. Masternak M.M., Bartke A., Wang F., Spong A., Gesing A., Fang Y., Salmon A.B., Hughes L.F., Liberati T., Boparai R., Kopchick J.J., Westbrook R. Metabolic effects of intra-abdominal fat in GHRKO mice. Aging Cell 2012, 11:73-81.
55. Lo J.C., Ljubicic S., Leibiger B., Kern M., Leibiger I.B., Moede T., Kelly M.E., Chatterjee Bhowmick D., Murano I., Cohen P., Banks A.S., Khandekar M.J., Dietrich A., Flier J.S., Cinti S., Bluher M., Danial N.N., Berggren P.O., Spiegelman B.M. Adipsin is an adipokine that improves beta cell function in diabetes. Cell 2014, 158:41-53.
56. Hascup E.R., Wang F., Kopchick J.J., Bartke A. Inflammatory and glutamatergic homeostasis are involved in successful aging. J. Gerontol. A Biol. Sci. Med. Sci. 2015.
57. Sadagurski M., Landeryou T., Cady G., Kopchick J.J., List E.O., Berryman D.E., Bartke A., Miller R.A. Growth hormone modulates hypothalamic inflammation in long-lived pituitary dwarf mice. Aging Cell 2015.
58. Zhang G., Li J., Purkayastha S., Tang Y., Zhang H., Yin Y., Li B., Liu G., Cai D. Hypothalamic programming of systemic ageing involving IKK-beta, NF-kappaB and GnRH. Nature 2013, 497:211-216.
59. Bartke A., Wright J.C., Mattison J.A., Ingram D.K., Miller R.A., Roth G.S. Extending the lifespan of long-lived mice. Nature 2001, 414:412.
60. Brown-Borg H.M., Bartke A. GH and IGF1: roles in energy metabolism of long-living GH mutant mice. J. Gerontol. A Biol. Sci. Med. Sci. 2012, 67:652-660.
61. Betz C., Hall M.N. Where is mTOR and what is it doing there?. J. Cell Biol. 2013, 203:563-574.
62. Harrison D.E., Strong R., Sharp Z.D., Nelson J.F., Astle C.M., Flurkey K., Nadon N.L., Wilkinson J.E., Frenkel K., Carter C.S., Pahor M., Javors M.A., Fernandez E., Miller R.A. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 2009, 460:392-395.
63. Kucia M., Masternak M., Liu R., Shin D.M., Ratajczak J., Mierzejewska K., Spong A., Kopchick J.J., Bartke A., Ratajczak M.Z. The negative effect of prolonged somatotrophic/insulin signaling on an adult bone marrow-residing population of pluripotent very small embryonic-like stem cells (VSELs). Age (Dordr.) 2013, 35:315-330.
64. Stout M.B., Tchkonia T., Pirtskhalava T., Palmer A.K., List E.O., Berryman D.E., Lubbers E.R., Escande C., Spong A., Masternak M.M., Oberg A.L., LeBrasseur N.K., Miller R.A., Kopchick J.J., Bartke A., Kirkland J.L. Growth hormone action predicts age-related white adipose tissue dysfunction and senescent cell burden in mice. Aging (Albany NY) 2014, 6:575-586.
65. Baker D.J., Wijshake T., Tchkonia T., LeBrasseur N.K., Childs B.G., van de Sluis B., Kirkland J.L., van Deursen J.M. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature 2011, 479:232-236.
66. Al-Regaiey K.A., Masternak M.M., Bonkowski M., Sun L., Bartke A. Long-lived growth hormone receptor knockout mice: interaction of reduced insulin-like growth factor 1/insulin signaling and caloric restriction. Endocrinology 2005, 146:851-860.
67. Wang Z., Al-Regaiey K.A., Masternak M.M., Bartke A. Adipocytokines and lipid levels in Ames dwarf and calorie-restricted mice. J. Gerontol. A Biol. Sci. Med. Sci. 2006, 61:323-331.
68. Westbrook R. The Effects of Altered Growth Hormone Signaling on Murine Metabolism 2012, Southern Illinois University, Carbondale.
69. Laron Z. The GH-IGF1 axis and longevity. the paradigm of IGF1 deficiency. Hormones (Athens) 2008, 7:24-27.
70. Guevara-Aguirre J., Balasubramanian P., Guevara-Aguirre M., Wei M., Madia F., Cheng C.W., Hwang D., Martin-Montalvo A., Saavedra J., Ingles S., de Cabo R., Cohen P., Longo V.D. Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans. Sci. Transl. Med. 2011, 3:70ra13.
71. Oliveira J.L., Aguiar-Oliveira M.H., D'Oliveira A., Pereira R.M., Oliveira C.R., Farias C.T., Barreto-Filho J.A., Anjos-Andrade F.D., Marques-Santos C., Nascimento-Junior A.C., Alves E.O., Oliveira F.T., Campos V.C., Ximenes R., Blackford A., Parmigiani G., Salvatori R. Congenital growth hormone (GH) deficiency and atherosclerosis: effects of GH replacement in GH-naive adults. J. Clin. Endocrinol. Metab. 2007, 92:4664-4670.
72. Suh Y., Atzmon G., Cho M.O., Hwang D., Liu B., Leahy D.J., Barzilai N., Cohen P. Functionally significant insulin-like growth factor I receptor mutations in centenarians. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:3438-3442.
73. Rozing M.P., Mooijaart S.P., Beekman M., Wijsman C.A., Maier A.B., Bartke A., Westendorp R.G., Slagboom E.P., van Heemst D. C-reactive protein and glucose regulation in familial longevity. Age (Dordr.) 2011, 33:623-630.
74. Wijsman C.A., Rozing M.P., Streefland T.C., le Cessie S., Mooijaart S.P., Slagboom P.E., Westendorp R.G., Pijl H., van Heemst D., G.Leiden Longevity Study Familial longevity is marked by enhanced insulin sensitivity. Aging Cell 2011, 10:114-121.
75. Samaras T.T., Elrick H., Storms L.H. Is height related to longevity?. Life Sci. 2003, 72:1781-1802.
76. Samaras T.T., Bartke A., Rollo C.D. Human body size and the laws of scaling: physiological, performance, growth, longevity and ecological ramifications 2007, Nova Science Publishers, New York.
77. He Q., Morris B.J., Grove J.S., Petrovitch H., Ross W., Masaki K.H., Rodriguez B., Chen R., Donlon T.A., Willcox D.C., Willcox B.J. Shorter men live longer: association of height with longevity and FOXO3 genotype in American men of Japanese ancestry. PLoS One 2014, 9.
78. Tan Q., Soerensen M., Kruse T.A., Christensen K., Christiansen L. A novel permutation test for case-only analysis identifies epistatic effects on human longevity in the FOXO gene family. Aging Cell 2013, 12:690-694.
79. Willcox B.J., Donlon T.A., He Q., Chen R., Grove J.S., Yano K., Masaki K.H., Willcox D.C., Rodriguez B., Curb J.D. FOXO3A genotype is strongly associated with human longevity. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:13987-13992.